help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Vercaeren, I.
Right arrow Articles by Heyns, W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Vercaeren, I.
Right arrow Articles by Heyns, W.

Endocrinology, Vol 137, 4713-4720, Copyright © 1996 by Endocrine Society


ARTICLES

Androgens transcriptionally regulate the expression of cystatin-related protein and the C3 component of prostatic binding protein in rat ventral prostate and lacrimal gland

I Vercaeren, H Vanaken, A Devos, B Peeters, G Verhoeven and W Heyns
Laboratory for Experimental Medicine and Endocrinology, Onderwijs en Navorsing, Gasthuisberg, Leuven, Belgium.

In this report, it is demonstrated that the C3 component of prostatic binding protein (PBP) is also expressed and androgen regulated in the exorbital lacrimal gland, as shown previously for cystatin-related protein (CRP), another abundant secretory protein from the ventral prostate. The presence of C3 messenger RNA (mRNA) could be demonstrated by both Northern blot hybridization and PCR amplification and sequencing. The mRNAs encoding the C1 and C2 components of PBP, however, were undetectable. At the protein level, the C3 component in the lacrimal gland is glycosylated and linked by disulfide bridges to a new 10-kDa component not reacting with the PBP antiserum. As shown previously for CRP, the expression of C3 in the lacrimal gland requires the simultaneous presence of androgens and a functional androgen receptor. The effects of castration and androgen treatment on CRP and C3 mRNA concentrations were studied by Northern blot and dot blot hybridization; effects on transcription rates were determined by nuclear run-on assay. Two days after castration, the relative abundance of CRP mRNA had declined significantly (P < 0.01) to 10.5 +/- 1.5% (+/- SEM) of precastration levels in the prostate and to 14.5 +/- 8.0% in the lacrimal gland; the transcription rates declined to 14.3% and 10.0%, respectively. The C3 mRNA level and transcription rate in the prostate showed a more moderate decrease (P < 0.05) to 40.6 +/- 8.5% and 41.7%, but were hardly measurable in the lacrimal gland. Androgen administration resulted in a rapid increase in the transcription rates, which reached or exceeded control levels after 6-9 h of treatment and clearly preceded the increase in mRNA levels. It is concluded that the lacrimal gland, which can be studied conveniently in female and long term androgen-depleted animals offers a suitable model for the study of androgen-regulated gene expression.


This article has been cited by other articles:


Home page
IOVSHome page
S. G. Remington, J. M. Crow, and J. D. Nelson
Secretoglobins: Lacrimal Gland-Specific Rabbit Lipophilin mRNAs
Invest. Ophthalmol. Vis. Sci., July 1, 2008; 49(7): 2856 - 2862.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. ProteomicsHome page
C. Cayatte, C. Pons, J.-M. Guigonis, J. Pizzol, L. Elies, P. Kennel, D. Rouquie, R. Bars, B. Rossi, and M. Samson
Protein Profiling of Rat Ventral Prostate following Chronic Finasteride Administration: Identification and Localization of a Novel Putative Androgen-regulated Protein
Mol. Cell. Proteomics, November 1, 2006; 5(11): 2031 - 2043.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
S. G. Remington and J. D. Nelson
Secretoglobins: Sexually Dimorphic Expression of Androgen-Binding Protein mRNA in Mouse Lacrimal Glands
Invest. Ophthalmol. Vis. Sci., January 1, 2005; 46(1): 31 - 38.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
C. Nellemann, M. Dalgaard, H. R. Lam, and A. M. Vinggaard
The Combined Effects of Vinclozolin and Procymidone Do Not Deviate from Expected Additivity in Vitro and in Vivo
Toxicol. Sci., February 1, 2003; 71(2): 251 - 262.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
A. M. Vinggaard, C. Nellemann, M. Dalgaard, E. B. Jorgensen, and H. R. Andersen
Antiandrogenic Effects in Vitro and in Vivo of the Fungicide Prochloraz
Toxicol. Sci., October 1, 2002; 69(2): 344 - 353.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. Alvarez, J. Vinas, J. M. M. Alonso, J. P. Albar, K. Ashman, and P. Dominguez
Characterization and Cloning of Two Isoforms of Heteroglobin, a Novel Heterodimeric Glycoprotein of the Secretoglobin-Uteroglobin Family Showing Tissue-specific and Sex Differential Expression
J. Biol. Chem., January 4, 2002; 277(1): 233 - 242.
[Abstract] [Full Text]


Home page
Ann. N. Y. Acad. Sci.Home page
R. I. LEHRER, T. NGUYEN, C. ZHAO, C. X. HA, and B. J. GLASGOW
Secretory Lipophilins: A Tale of Two Species
Ann. N.Y. Acad. Sci., December 1, 2000; 923(1): 59 - 67.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1996 by The Endocrine Society